Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Authors
Dentro, S. C.Leshchiner, I.
Haase, K.
Tarabichi, M.
Wintersinger, J.
Deshwar, A. G.
Yu, K.
Rubanova, Y.
Macintyre, G.
Demeulemeester, J.
Vázquez-García, I.
Kleinheinz, K.
Livitz, D. G.
Malikic, S.
Donmez, N.
Sengupta, S.
Anur, P.
Jolly, C.
Cmero, M.
Rosebrock, D.
Schumacher, S. E.
Fan, Y.
Fittall, M.
Drews, R. M.
Yao, X.
Watkins, T. B. K.
Lee, J.
Schlesner, M.
Zhu, H.
Adams, D. J.
McGranahan, N.
Swanton, C.
Getz, G.
Boutros, P. C.
Imielinski, M.
Beroukhim, R.
Sahinalp, S. C.
Ji, Y.
Peifer, M.
Martincorena, I.
Markowetz, F.
Mustonen, V.
Yuan, K.
Gerstung, M.
Spellman, P. T.
Wang, W.
Morris, Q. D.
Wedge, David C
Van Loo, P.
Affiliation
Cancer Genomics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7LIssue Date
2021
Metadata
Show full item recordAbstract
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important clinical challenge. However, the extent, origin, and drivers of ITH across cancer types are poorly understood. To address this, we extensively characterize ITH across whole-genome sequences of 2,658 cancer samples spanning 38 cancer types. Nearly all informative samples (95.1%) contain evidence of distinct subclonal expansions with frequent branching relationships between subclones. We observe positive selection of subclonal driver mutations across most cancer types and identify cancer type-specific subclonal patterns of driver gene mutations, fusions, structural variants, and copy number alterations as well as dynamic changes in mutational processes between subclonal expansions. Our results underline the importance of ITH and its drivers in tumor evolution and provide a pan-cancer resource of comprehensively annotated subclonal events from whole-genome sequencing data.Citation
Dentro SC, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar AG, et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell. 2021 Apr;184(8):2239-2254.e39.Journal
CellDOI
10.1016/j.cell.2021.03.009PubMed ID
33831375Additional Links
https://dx.doi.org/10.1016/j.cell.2021.03.009Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.cell.2021.03.009
Scopus Count
Collections
Related articles
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.
- Authors: McGranahan N, Favero F, de Bruin EC, Birkbak NJ, Szallasi Z, Swanton C
- Issue date: 2015 Apr 15
- Principles of Reconstructing the Subclonal Architecture of Cancers.
- Authors: Dentro SC, Wedge DC, Van Loo P
- Issue date: 2017 Aug 1
- Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
- Authors: Morris LG, Riaz N, Desrichard A, Şenbabaoğlu Y, Hakimi AA, Makarov V, Reis-Filho JS, Chan TA
- Issue date: 2016 Mar 1
- Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
- Authors: Kim TM, Jung SH, An CH, Lee SH, Baek IP, Kim MS, Park SW, Rhee JK, Lee SH, Chung YJ
- Issue date: 2015 Oct 1
- Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations.
- Authors: Tai AS, Peng CH, Peng SC, Hsieh WP
- Issue date: 2018